Publications featuring AssayQuant technology

Peer-reviewed studies from drug discovery and academic labs featuring PhosphoSens® continuous kinase and phosphatase assays, KinSight™ profiling services, and the Sox chemistry they are built on.

190publications
186kinase studies
4phosphatase studies
2001–2026years covered

Showing 190 publications

A Constellation of Fluorescent Biosensors to Illuminate the Galaxy of Protein Kinases

Abbura T, Morris MC · Chembiochem 2026

Multiple Mechanism & structural biologyAssay & sensor technologyReview Technology & reviews

An S752D activation loop mutation dynamically primes Muscle-Specific Kinase for activation

Prömer JJ, Murphy JW, Lemmon MA, … Herbst R · Biochem J 2026

MuSK Mechanism & structural biology PhosphoSens

Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations

Junttila MR, Repellin CE, Salaniwal S, … Friedman LS · Cancer Res 2026

EGFR Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Erk inhibitors intercept Erk-mediated negative feedback while imposing cell-cycle arrest and activating p38

Darash-Yahana M, Soudah N, Baskin A, … Engelberg D · iScience 2026

ERK1/2 Signaling biology PhosphoSens

Global protein-ligand binding affinity profiling via photocatalytic labeling

Warren CD, Yardeny N, Peng S, … Geri JB · Nat Commun 2026

Multiple Selectivity & kinome profilingCell & tissue lysate assays PhosphoSens

Identification of a New Phosphorylated Host Interactor of the Epstein-Barr Virus (EBV) Kinase BGLF4 Suggests Key Points for EBV-Specific Antiviral Drug Targeting

Kögler M, Wangen C, Hammerschmitt A, … Marschall M · Int J Mol Sci 2026

BGLF4 (EBV kinase) Inhibitor discovery & SARAssay & sensor technology PhosphoSens

Let the peptides shine: SOX (Sulfonamido-OXine)-labelled peptides for direct kinase and phosphatase monitoring

Papagora LE, Cochrane SA · RSC Chem Biol 2026

Multiple Inhibitor discovery & SARMechanism & structural biologyCell & tissue lysate assaysAssay & sensor technologyPhosphatase biologyReview Technology & reviews

Molecular modulators of cyclin-dependent kinase 4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening

Surender S, Haeusser LA, Kuhlburger L, … Tabatabai G · Neuro Oncol 2026

CDK2/Cyclin E1 Inhibitor discovery & SAR PhosphoSens

Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase Inhibitors

Liang XJ, Albertini C, Kronenberger T, … Gehringer M · J Med Chem 2026

BMX Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Selective Inhibitor of Protein Kinase PKN3 Generated by Conjugation of a Structurally Optimized Bumped-(2-Aminoethyl)-8-anilinoisoquinoline-5-sulfonamide (H-9) with d-Arginine-Rich Chain

Smorodina V, Jääger EL, Sõrmus T, … Viht K · Molecules 2026

PKN3, PKN1 Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Structural Studies of Fourth-Generation EGFR Inhibitors Reveal Insights into Selective T790M and C797S Targeting

Damghani T, Song S, Lin KS, … Heppner DE · ACS Med Chem Lett 2026

EGFR and EGFR mutants Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Structural basis of the cyclin Y/14-3-3 protein-mediated activation of CDK16

Kohoutova K, Kosek D, Brzezina A, … Obsil T · Nat Commun 2026

CDK16 Mechanism & structural biology PhosphoSens

TAS3351 is a brain penetrable EGFR-TKI that overcomes T790M and C797S resistant mutations

Kasuga H, Kataoka Y, Yamamoto F, … Mizuarai S · Commun Med (Lond) 2026

EGFR and EGFR mutants Signaling biology PhosphoSens

18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors

Giddabasappa A, Jiang ZK, Yang B, … Dann SG · Mol Cancer Ther 2025

CDK2, CDK4/6, CDK7, CDK9 Inhibitor discovery & SAR PhosphoSens

A "Ligand First" Approach toward Selective, Covalent JNK2/3 Inhibitors

Wydra VR, Plank N, Zwirner S, … Laufer S · J Med Chem 2025

JNK2/3 Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2

Hillebrand L, Wang G, Rasch A, … Gehringer M · RSC Med Chem 2025

JAK3, MK2 Covalent inhibitor kineticsInhibitor discovery & SARMechanism & structural biology PhosphoSens

Application and Cross-Validation of a High-Throughput SPR Method for Characterizing Covalent Binding Ligands

Zhou W, Ye X, Pandey S, Du X · ACS Omega 2025

MK2 Covalent inhibitor kineticsAssay & sensor technology PhosphoSens

Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL

Ketzer F, Büttner U, Geist D, … Ushmorov A · Blood Adv 2025

Kinome Profiling (GSK3) Inhibitor discovery & SARSelectivity & kinome profiling KinSight services

COOKIE-Pro: covalent inhibitor binding kinetics profiling on the proteome scale

Lin H, Yang B, Ding L, … Wang J · Nat Commun 2025

Not specified Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Cancer hotspot mutations rewire ERK2 specificity by selective exclusion of docking interactions

Torres Robles J, Stiegler AL, Boggon TJ, Turk BE · J Biol Chem 2025

ERK2 and mutants Mechanism & structural biology PhosphoSens

Covalent Alkynylpyridopyrimidinones Targeting Cysteine 775 of the Epidermal Growth Factor Receptor Overcome Resistance to Current Therapies

Stewart HL, Bordoni C, Jennings CE, … Waring MJ · J Med Chem 2025

EGFR L858R/T790M Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling KinSight services

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies

Wichroski M, Liu SQ, Zasadil LM, … Lees E · Cancer Immunol Res 2025

DGKα, DGKζ (lipid kinases) Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Discovery of STX-721, a Covalent, Potent, and Highly Mutant-Selective EGFR/HER2 Exon20 Insertion Inhibitor for the Treatment of Non-Small Cell Lung Cancer

Milgram BC, Borrelli DR, Brooijmans N, … Guzman-Perez A · J Med Chem 2025

EGFR/HER2 exon 20 mutants Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding

Morese PA, Ahmad A, Martin MP, … Waring MJ · Commun Chem 2025

EGFR Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling KinSight services

Inhibition of Muscle-Specific Protein Kinase (MuSK) Releases Organophosphate-Aged Acetylcholinesterase (AChE) from C2C12 Cells

Moncada-Restrepo M, Eysoldt S, Medina J, … Chambers JW · Toxics 2025

MuSK Inhibitor discovery & SAR PhosphoSens

Novel Flavonoid Derivatives Show Potent Efficacy in Human Lymphoma Models

Gaudio E, Biniecka P, Arribas AJ, … Stoicescu DF · EJHaem 2025

Kinome Profiling Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Profiling and Optimizing Targeted Covalent Inhibitors through EGFR-Guided Studies

Damghani T, Chitnis SP, Abidakun OA, … Heppner DE · J Med Chem 2025

EGFR Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Proteome-wide ligandability maps of drugs with diverse cysteine-reactive chemotypes

Tian C, Sun L, Liu K, … Yang J · Nat Commun 2025

JAK1 Covalent inhibitor kineticsInhibitor discovery & SAR PhosphoSens

STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models

Pagliarini RA, Henderson JA, Milgram BC, … Stuart DD · Clin Cancer Res 2025

EGFR/HER2 exon 20 mutants Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

The role of kinase domain dimerization in EGFR activation

Petrova ZO, Han L, Tsutsui Y, … Lemmon MA · Structure 2025

EGFR Mechanism & structural biology PhosphoSens

Time-evolved metrics for safety pharmacological assessments of small molecules and biologics

Srinivasan B · Br J Pharmacol 2025

Not specified Selectivity & kinome profilingReview PhosphoSens

Type II kinase inhibitors that target Parkinson's disease-associated LRRK2

Raig ND, Surridge KJ, Sanz-Murillo M, … Knapp S · Sci Adv 2025

LRRK2 Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Un-LOK-ing a New Approach for Conformational Selective Targeting of STK10 (LOK)

Dettenhöfer M, Tandara LN, Amrhein JA, … Hanke T · ACS Med Chem Lett 2025

STK10 Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations

Tangpeerachaikul A, Mente S, Magrino J, … Pelish HE · Mol Cancer Ther 2025

ROS1 Inhibitor discovery & SARMechanism & structural biology PhosphoSens

A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition

Lenchner DS, Petrova ZO, Hunihan L, … Wilson FH · NPJ Precis Oncol 2024

EGFR and EGFR mutants Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Conformation selection by ATP-competitive inhibitors and allosteric communication in ERK2

Anderson JW, Vaisar D, Jones DN, … Ahn NG · Elife 2024

ERK2 Mechanism & structural biology PhosphoSens

Demystifying Functional Parameters for Irreversible Enzyme Inhibitors

Heppner DE, Ogboo BC, Urul DA, … Gehringer M · J Med Chem 2024

Covalent inhibitors (EGFR) Covalent inhibitor kineticsSelectivity & kinome profiling KinSight services

Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SAr Electrophiles

Schwarz M, Kurkunov M, Wittlinger F, … Gehringer M · J Med Chem 2024

FGFR4 Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants

Capener JL, Vasta JD, Katis VL, … Bashore FM · Front Chem Biol 2024

SYK and SYK mutants Inhibitor discovery & SAR PhosphoSens

Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors

Scheuplein F, Renner F, Campbell JE, … Bischoff JR · Front Immunol 2024

STK17B Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Exploring 2-Sulfonylpyrimidine Warheads as Acrylamide Surrogates for Targeted Covalent Inhibition: A BTK Story

Moraru R, Valle-Argos B, Minton A, … Baud MGJ · J Med Chem 2024

BTK Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors

Davison JR, Hadjithomas M, Romeril SP, … Verdine GL · J Med Chem 2024

CDK1, CDK2, CDK7 Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Wittlinger F, Ogboo BC, Shevchenko E, … Heppner DE · Commun Chem 2024

EGFR and EGFR mutants Inhibitor discovery & SARMechanism & structural biology AQT co-authored

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Lin JJ, Horan JC, Tangpeerachaikul A, … Drilon A · Cancer Discov 2024

Multiple (ALK & ALK mutants; TRKA, TRKB, TRKC) Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Organ-specific electrophile responsivity mapping in live C. elegans

Liu J, Kulkarni A, Gao YQ, … Aye Y · Cell 2024

Multiple Selectivity & kinome profiling KinSight services

Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors

Chaudhry S, Castro JR, Totiger TM, … Feng Y · ACS Med Chem Lett 2024

STK17A/B Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Steady State and Time-Dependent Fluorescent Peptide Assays for Protein Kinases

Sammons RM, Devkota AK, Kaoud TS, … Dalby KN · Curr Protoc 2024

Multiple Covalent inhibitor kineticsAssay & sensor technology PhosphoSens

The mechanism of allosteric activation of SYK kinase derived from multiple phospho-ITAM-bound structures

Bradshaw WJ, Harris G, Gileadi O, Katis VL · Structure 2024

SYK Covalent inhibitor kineticsMechanism & structural biology PhosphoSens

Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent "Type V" Kinase Inhibitors

Wittlinger F, Chitnis SP, Pham CD, … Heppner DE · J Med Chem 2024

EGFR and EGFR mutants Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR

Pemberton N, Compagne N, Argyrou A, … Ward RA · ACS Med Chem Lett 2024

EGFR and EGFR mutants Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination

Evonuk KS, Wang S, Mattie J, … Marušić S · Acta Neuropathol Commun 2023

Kinome Profiling (BTK) Inhibitor discovery & SARSelectivity & kinome profiling KinSight services

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

Berko ER, Witek GM, Matkar S, … Mossé YP · Nat Commun 2023

ALK and ALK Mutants Signaling biology PhosphoSens

Controlling Ibrutinib's Conformations about Its Heterobiaryl Axis to Increase BTK Selectivity

Toenjes ST, Heydari BS, Albright ST, … Gustafson JL · ACS Med Chem Lett 2023

BTK Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1

Lu W, Liu Y, Gao Y, … Gray NS · J Med Chem 2023

JNK1-JNK3 Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Linear motif specificity in signaling through p38α and ERK2 mitogen-activated protein kinases

Torres Robles J, Lou HJ, Shi G, … Turk BE · Proc Natl Acad Sci U S A 2023

MAPK Signaling biology PhosphoSens

Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability

Novak L, Petrosino M, Pasquo A, … Consalvi V · Cancers (Basel) 2023

ERK2 Signaling biology PhosphoSens

NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations

Drilon A, Horan JC, Tangpeerachaikul A, … Lin JJ · Cancer Discov 2023

ROS1 and ROS1 mutants Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order-Disorder Transition Upon Activation

Weng JH, Trilling CR, Kaila Sharma P, … Taylor SS · J Mol Biol 2023

LRRK2 and LRRK2 mutants Inhibitor discovery & SAR PhosphoSens

Phosphorylation of tyrosine 90 in SH3 domain is a new regulatory switch controlling Src kinase

Koudelková L, Pelantová M, Brůhová Z, … Rösel D · Elife 2023

SRC Mechanism & structural biology PhosphoSens

Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors

Hoyt KW, Urul DA, Ogboo BC, … Heppner DE · J Med Chem 2023

EGFR Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profilingReview AQT co-authored

Proteome-wide screening for mitogen-activated protein kinase docking motifs and interactors

Shi G, Song C, Torres Robles J, … Turk BE · Sci Signal 2023

MAPKs, JNK1, p38α Signaling biology PhosphoSens

Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors

Liu S, Kormos BL, Knafels JD, … Filipski KJ · J Biol Chem 2023

PDK1-4 (BCKDK) Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology KinSight services

Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?

Tsitokana ME, Lafon PA, Prézeau L, … Rondard P · Int J Mol Sci 2023

LRRK2 Review Technology & reviews

The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants

Petrosino M, Novak L, Pasquo A, … Chiaraluce R · Hum Genomics 2023

MAPK1/MAPK3 variants Signaling biology PhosphoSens

Triple targeting of mutant EGFR, COX-2, and 15-LOX: design and synthesis of novel quinazolinone tethered phenyl urea derivatives for anti-inflammatory and anticancer evaluation

Kothayer H, Rezq S, Abdelkhalek AS, … Elbaramawi SS · J Enzyme Inhib Med Chem 2023

EGFR and EGFR L858R/T790M Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations

van Alderwerelt van Rosenburgh IK, Lu DM, Grant MJ, … Tsutsui Y · Nat Commun 2022

EGFR and EGFR variants Mechanism & structural biology PhosphoSens

Casein kinase 1 and disordered clock proteins form functionally equivalent, phospho-based circadian modules in fungi and mammals

Marzoll D, Serrano FE, Shostak A, … Brunner M · Proc Natl Acad Sci U S A 2022

CK1 Signaling biology PhosphoSens

Deactivatable Bisubstrate Inhibitors of Protein Kinases

Sõrmus T, Lavogina D, Enkvist E, … Viht K · Molecules 2022

PKAc Signaling biology PhosphoSens

High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery

Srinivasan B, Flórez Weidinger JD, Zhai X, … Steigele S · SLAS Discov 2022

Multiple, names not disclosed Inhibitor discovery & SARAssay & sensor technology PhosphoSens

Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H

Schütz M, Müller R, Socher E, … Marschall M · Int J Mol Sci 2022

pUL97 that represents a viral CDK ortholog (vCDK) Signaling biology PhosphoSens

Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2

Singh RK, Soliman A, Guaitoli G, … Versées W · Proc Natl Acad Sci U S A 2022

LRRK2 Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Neurospora casein kinase 1a recruits the circadian clock protein FRQ via the C-terminal lobe of its kinase domain

Marzoll D, Serrano FE, Diernfellner ACR, Brunner M · FEBS Lett 2022

CK1a, CK1a- p1, and CK1a- p2 Signaling biology PhosphoSens

Shining Light on Protein Kinase Biomarkers with Fluorescent Peptide Biosensors

Morris MC · Life (Basel) 2022

Multiple Assay & sensor technologyReview Technology & reviews

Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448)

Heppner DE, Wittlinger F, Beyett TS, … Hershberger PA · ACS Med Chem Lett 2022

EGFR and HER2 Inhibitor discovery & SARMechanism & structural biology AQT co-authored

The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction

Griem-Krey N, Gauger SJ, Gowing EK, … Wellendorph P · Biomed Pharmacother 2022

CaMKIIα Signaling biology PhosphoSens

A Novel High-Throughput FLIPR Tetra-Based Method for Capturing Highly Confluent Kinetic Data for Structure-Kinetic Relationship Guided Early Drug Discovery

Khurana P, McWilliams L, Wingfield J, … Srinivasan B · SLAS Discov 2021

Multiple kinases, names not disclosed Covalent inhibitor kineticsInhibitor discovery & SARAssay & sensor technologyReview Technology & reviews

A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism

Ghazanfari D, Noori MS, Bergmeier SC, … Goetz DJ · Bioorg Med Chem 2021

GSK-3 (Ser/Thr) Inhibitor discovery & SAR PhosphoSens

Cellular model system to dissect the isoform-selectivity of Akt inhibitors

Quambusch L, Depta L, Landel I, … Rauh D · Nat Commun 2021

Akt (Ser/Thr) Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia

Bata N, Chaikuad A, Bakas NA, … Cosford NDP · J Med Chem 2021

STK3/4 (Ser/Thr) Inhibitor discovery & SAR PhosphoSens

Separase cleaves the kinetochore protein Meikin at the meiosis I/II transition

Maier NK, Ma J, Lampson MA, Cheeseman IM · Dev Cell 2021

Plk1 (Ser/Thr) Covalent inhibitor kinetics PhosphoSens

Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis

Gilon C, Klazas M, Lahiani A, … Lazarovici P · JACS Au 2021

NTRK1 (TRKA)/ NTRK2 (TRKB) (Tyr) Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology AQT co-authored

A fluorescent probe for monitoring PTP-PEST enzymatic activity

Casey GR, Stains CI · Analyst 2020

Phosphatase non-receptor type 12 (PTPN12 or PTP-PEST) Assay & sensor technologyPhosphatase biology Technology origin

Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition

Liclican A, Serafini L, Xing W, … Feng JY · Biochim Biophys Acta Gen Subj 2020

BTK (Tyr) Covalent inhibitor kineticsSelectivity & kinome profiling PhosphoSens

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

Guo WH, Qi X, Yu X, … Wang J · Nat Commun 2020

BTK Covalent inhibitor kineticsInhibitor discovery & SAR PhosphoSens

Insight into the Therapeutic Selectivity of the Irreversible EGFR Tyrosine Kinase Inhibitor Osimertinib through Enzyme Kinetic Studies

Zhai X, Ward RA, Doig P, Argyrou A · Biochemistry 2020

EGFR (Tyr) wild-type & oncogenic mutants, Covalent ... Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Modular bioengineered kinase sensorsscaffold protein-mediated split-luciferase complementation

Xu X, Lemmens LJM, den Hamer A, … Brunsveld L · Chem Sci 2020

PKA Cell & tissue lysate assaysAssay & sensor technology PhosphoSens

Neurotropic activity and safety of methylene-cycloalkylacetate (MCA) derivative 3-(3-allyl-2-methylenecyclohexyl) propanoic acid

Lahiani A, Haham-Geula D, Lankri D, … Lazarovici P · ACS Chem Neurosci 2020

Multiple kinases (Ser/Thr & Tyr) Signaling biology AQT co-authored

Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases

Sheetz JB, Mathea S, Karvonen H, … Lemmon MA · Mol Cell 2020

RTK pseudokinases Mechanism & structural biology PhosphoSens

An ultrasensitive fiveplex activity assay for cellular kinases

Smolko CM, Janes KA · Sci Rep 2019

AKT, IKKβ, JNK1-3, MK2 Selectivity & kinome profiling PhosphoSens

Design and synthesis of fluorescent activity probes for protein phosphatases

Casey GR, Beck JR, Stains CI · Methods Enzymol 2019

Not specified Inhibitor discovery & SARCell & tissue lysate assaysAssay & sensor technologyPhosphatase biology Technology origin

Enrichment of Aurora B kinase at the inner kinetochore controls outer kinetochore assembly

Bonner MK, Haase J, Swinderman J, … Kelly AE · J Cell Biol 2019

Aurora B (Ser/Thr) Signaling biology PhosphoSens

Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells

Broughton K, Korski K, Echeagaray O, … Sussman MA · Gene Ther 2019

AKT1-3, CDK1/3-6, CK1, ERK1/2, JNK1-3, p38a/b/g/d, PIM1, ... Selectivity & kinome profilingAssay & sensor technology AQT co-authored

Interrogating Protein Phosphatases with Chemical Activity Probes

Casey GR, Stains CI · Chemistry 2018

Phosphatases Covalent inhibitor kineticsAssay & sensor technologyPhosphatase biologyReview Technology origin

Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms

Antenucci L, Hytönen VP, Ylänne J · J Biol Chem 2018

Syk (Tyr) Mechanism & structural biologyAssay & sensor technology PhosphoSens

Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR

Planken S, Behenna DC, Nair SK, … Lafontaine J · J Med Chem 2017

EGFR (Tyr) wild-type & oncogenic mutants: exon 19 deletion ... Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Discovery of a Potent BTK Inhibitor with a Novel Binding Mode by Using Parallel Selections with a DNA-Encoded Chemical Library

Cuozzo JW, Centrella PA, Gikunju D, … Clark MA · Chembiochem 2017

BTK (Tyr) Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Measuring Kinase Activity-A Global Challenge

Cann ML, McDonald IM, East MP, … Graves LM · J Cell Biochem 2017

Multiple Selectivity & kinome profilingReview Technology & reviews

Quantification of Cell Signaling Networks Using Kinase Activity Chemosensors

Beck JR, Harris EN, Stains CI · Methods Mol Biol 2017

Multiple Cell & tissue lysate assaysAssay & sensor technologyReview Technology origin

An algebraic model to determine substrate kinetic parameters by global nonlinear fit of progress curves

Reytor González ML, Cornell-Kennon S, Schaefer E, Kuzmič P · Anal Biochem 2016

EGFR (Tyr) Assay & sensor technology AQT co-authored

Bistability of a coupled Aurora B kinase-phosphatase system in cell division

Zaytsev AV, Segura-Peña D, Godzi M, … Grishchuk EL · Elife 2016

Aurora A & B (Ser/Thr) Assay & sensor technologyPhosphatase biology PhosphoSens

Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants

Cheng H, Nair SK, Murray BW, … Kath JC · J Med Chem 2016

EGFR & Mutants (Tyr), Covalent Inhibitors Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Disulfide-activated protein kinase G Iα regulates cardiac diastolic relaxation and fine-tunes the Frank-Starling response

Scotcher J, Prysyazhna O, Boguslavskyi A, … Eaton P · Nat Commun 2016

PKG (Ser/Thr) Signaling biology PhosphoSens

Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Iα Oxidation

Prysyazhna O, Burgoyne JR, Scotcher J, … Eaton P · J Biol Chem 2016

PKG (Ser/Thr) Signaling biology PhosphoSens

Phosphorylation of the dimeric cytoplasmic domain of the phytosulfokine receptor, PSKR1

Muleya V, Marondedze C, Wheeler JI, … Irving HR · Biochem J 2016

PSKR1 (Ser/Thr) Signaling biology PhosphoSens

Temporal Analysis of PP2A Phosphatase Activity During Insulin Stimulation Using a Direct Activity Probe

Beck JR, Truong T, Stains CI · ACS Chem Biol 2016

PP2A (Ser/Thr Phosphatase) Cell & tissue lysate assaysAssay & sensor technologyPhosphatase biology Technology origin

A real-time, fluorescence-based assay for Rho-associated protein kinase activity

Kelly MI, Bechtel TJ, Reddy DR, … Stains CI · Anal Chim Acta 2015

ROCK (Ser/Thr) Inhibitor discovery & SARAssay & sensor technology Technology origin

Cyclin-dependent kinase 5 regulates degranulation in human eosinophils

Odemuyiwa SO, Ilarraza R, Davoine F, … Lacy P · Immunology 2015

CDK5 (Ser/Thr) Inhibitor discovery & SAR PhosphoSens

Design and evaluation of a real-time activity probe for focal adhesion kinase

Beck JR, Zhou X, Casey GR, Stains CI · Anal Chim Acta 2015

FAK (Tyr) Inhibitor discovery & SARSelectivity & kinome profilingAssay & sensor technology Technology origin

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

Hagel M, Miduturu C, Sheets M, … Guzi T · Cancer Discov 2015

FGFR4 (Tyr), Covalent Inhibitors Covalent inhibitor kineticsInhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Fluorescent Reporters and Biosensors for Probing the Dynamic Behavior of Protein Kinases

González-Vera JA, Morris MC · Proteomes 2015

Multiple Assay & sensor technologyReview Technology & reviews

Interrogating Endogenous Protein Phosphatase Activity with Rationally Designed Chemosensors

Beck JR, Lawrence A, Tung AS, … Stains CI · ACS Chem Biol 2015

PTP1B (Tyr Phosphatase) Cell & tissue lysate assaysAssay & sensor technologyPhosphatase biology Technology origin

Peptide-based biosensors

Liu Q, Wang J, Boyd BJ · Talanta 2015

Multiple Selectivity & kinome profilingAssay & sensor technologyReview Technology & reviews

Protein kinase profiling assays: a technology review

Wang Y, Ma H · Drug Discov Today Technol 2015

Multiple Selectivity & kinome profilingReview Technology & reviews

A continuous and direct assay to monitor leucine-rich repeat kinase 2 activity

Silva RG, Geoghegan KF, Qiu X, Aulabaugh A · Anal Biochem 2014

LRRK2 (Ser/Thr) Inhibitor discovery & SARAssay & sensor technology PhosphoSens

An algebraic model for the kinetics of covalent enzyme inhibition at low substrate concentrations

Kuzmič P, Solowiej J, Murray BW · Anal Biochem 2014

EGFR (Tyr), Covalent Inhibitors Covalent inhibitor kinetics PhosphoSens

Cyclometalated iridium(III)-β-carboline complexes as potent autophagy-inducing agents

He L, Liao SY, Tan CP, … Mao ZW · Chem Commun (Camb) 2014

CDK1 & 2 (Ser/Thr) Signaling biology PhosphoSens

Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2

Szalewski DA, Beck JR, Stains CI · Bioorg Med Chem Lett 2014

LRRK2 (Ser/Thr) Inhibitor discovery & SARAssay & sensor technology Technology origin

Differential sensing of MAP kinases using SOX-peptides

Zamora-Olivares D, Kaoud TS, Jose J, … Anslyn EV · Angew Chem Int Ed Engl 2014

MAPKs, ERK1/2, JNK1/2/3, and Assay & sensor technology Technology origin

Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor

Dumble M, Crouthamel MC, Zhang SY, … Kumar R · PLoS One 2014

AKT 1, 2 & 3 (Ser/Thr) Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing

Tjin Tham Sjin R, Lee K, Walter AO, … Singh J · Mol Cancer Ther 2014

EGFR (Tyr), Covalent Inhibitors Covalent inhibitor kineticsInhibitor discovery & SAR PhosphoSens

Microfluidic probe for single-cell analysis in adherent tissue culture

Sarkar A, Kolitz S, Lauffenburger DA, Han J · Nat Commun 2014

AKT (Ser/Thr), Microfluidics Signaling biology PhosphoSens

Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models

Akl MR, Ayoub NM, Mohyeldin MM, … Sayed KA · PLoS One 2014

cMET/HGFR (Tyr) Inhibitor discovery & SAR PhosphoSens

Protein kinase C and extracellular signal-regulated kinase regulate movement, attachment, pairing and egg release in Schistosoma mansoni

Ressurreição M, De Saram P, Kirk RS, … Walker AJ · PLoS Negl Trop Dis 2014

PKC (Ser/Thr) Signaling biology PhosphoSens

Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine

Warthaka M, Adelmann CH, Kaoud TS, … Dalby KN · ACS Med Chem Lett 2014

MAPKs - ERK1& 2 (Ser/Thr) Inhibitor discovery & SARCell & tissue lysate assaysAssay & sensor technology Technology origin

SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells

Keller KE, Doctor ZM, Dwyer ZW, Lee YS · Mol Cell 2014

MAPKs - ERK1 & 2 (Ser/Thr) Signaling biology PhosphoSens

Selective mitogen activated protein kinase activity sensors through the application of directionally programmable D domain motifs

Peterson LB, Yaffe MB, Imperiali B · Biochemistry 2014

p38abdg (Ser/Thr) Inhibitor discovery & SARSelectivity & kinome profilingAssay & sensor technology Technology origin

Single cell kinase signaling assay using pinched flow coupled droplet microfluidics

Ramji R, Wang M, Bhagat AA, … Chen CH · Biomicrofluidics 2014

EGFR (Tyr). Microfluidics Inhibitor discovery & SARAssay & sensor technology PhosphoSens

Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studies

Sartini S, Coviello V, Bruno A, … La Motta C · J Med Chem 2014

VEGFR2/KDR and RET (Tyr) Inhibitor discovery & SAR PhosphoSens

Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors

Edupuganti R, Wang Q, Tavares CD, … Dalby KN · Bioorg Med Chem 2014

eEF-2K (Ser/Thr) Inhibitor discovery & SAR Technology origin

The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation

Paris D, Ait-Ghezala G, Bachmeier C, … Mullan M · J Biol Chem 2014

SYK (Tyr) Mechanism & structural biology PhosphoSens

Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance

Schwartz PA, Kuzmic P, Solowiej J, … Murray BW · Proc Natl Acad Sci U S A 2013

EGFR (Tyr), Covalent Inhibitors Covalent inhibitor kineticsInhibitor discovery & SAR PhosphoSens

Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F

Ma L, Clayton JR, Walgren RA, … Burkholder TP · Blood Cancer J 2013

JAK2 (Tyr) Inhibitor discovery & SARSelectivity & kinome profilingAssay & sensor technology PhosphoSens

Discovery of novel insulin-like growth factor-1 receptor inhibitors with unique time-dependent binding kinetics

Jin M, Petronella BA, Cooke A, … Mulvihill MJ · ACS Med Chem Lett 2013

IGF1R (Tyr) Inhibitor discovery & SAR AQT co-authored

Fluorescent sensors of protein kinases: from basics to biomedical applications

Nhu Ngoc Van T, Morris MC · Prog Mol Biol Transl Sci 2013

Multiple Mechanism & structural biologyAssay & sensor technologyReview Technology & reviews

Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock

Kaasik K, Kivimäe S, Allen JJ, … Fu YH · Cell Metab 2013

GSK3beta (Ser/Thr) Assay & sensor technology PhosphoSens

High-throughput screens for eEF-2 kinase

Devkota AK, Warthaka M, Edupuganti R, … Dalby KN · J Biomol Screen 2013

eEF-2K (Ser/Thr) Inhibitor discovery & SARAssay & sensor technology PhosphoSens

In-situ generation of differential sensors that fingerprint kinases and the cellular response to their expression

Zamora-Olivares D, Kaoud TS, Dalby KN, Anslyn EV · J Am Chem Soc 2013

MAPKs - ERK- 1/2, JNK-3 & p38g (Ser/Thr) Assay & sensor technology Technology origin

Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans

Evans EK, Tester R, Aslanian S, … Westlin WF · J Pharmacol Exp Ther 2013

BTK (Tyr), Covalent Inhibitors Covalent inhibitor kineticsInhibitor discovery & SAR PhosphoSens

Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform

Desai B, Dixon K, Farrant E, … Wright AG · J Med Chem 2013

ABL (Tyr), Microfluidics Inhibitor discovery & SAR PhosphoSens

Structural characterization of the RLCK family member BSK8: a pseudokinase with an unprecedented architecture

Grütter C, Sreeramulu S, Sessa G, Rauh D · J Mol Biol 2013

BSK5 & 8 (Ser/Thr) Mechanism & structural biology PhosphoSens

Biophysical and mechanistic insights into novel allosteric inhibitor of spleen tyrosine kinase

Hall J, Aulabaugh A, Rajamohan F, … Qiu X · J Biol Chem 2012

SYK (Tyr) Selectivity & kinome profilingMechanism & structural biology PhosphoSens

Identification of a hidden strain switch provides clues to an ancient structural mechanism in protein kinases

Oruganty K, Talathi NS, Wood ZA, Kannan N · Proc Natl Acad Sci U S A 2012

Aurora (Ser/Thr) Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Interrogating signaling nodes involved in cellular transformations using kinase activity probes

Stains CI, Tedford NC, Walkup TC, … Imperiali B · Chem Biol 2012

Not specified Cell & tissue lysate assaysAssay & sensor technology Technology origin

Spatially coordinated kinase signaling regulates local axon degeneration

Chen M, Maloney JA, Kallop DY, … Watts RJ · J Neurosci 2012

GSK-3 (Ser/Thr) Signaling biology PhosphoSens

Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungals

Grütter C, Simard JR, Mayer-Wrangowski SC, … Rauh D · ACS Chem Biol 2012

GSK-3 (Ser/Thr) Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology PhosphoSens

Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1

Tu Q, Zhang J, Dong LQ, … Chen J · J Biol Chem 2011

AKT (Ser/Thr) Phosphatase biology PhosphoSens

CHEK2 contribution to hereditary breast cancer in non-BRCA families

Desrichard A, Bidet Y, Uhrhammer N, Bignon YJ · Breast Cancer Res 2011

CHEK2 (Ser/Thr) Signaling biology PhosphoSens

Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site

Yang J, Campobasso N, Biju MP, … Oliff A · Chem Biol 2011

ABL (Tyr) Inhibitor discovery & SARMechanism & structural biology PhosphoSens

Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors

Chen Z, Forman LW, Miller KA, … Faller DV · Endocr Relat Cancer 2011

PKC-d (Ser/Thr) Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt

Durgadoss L, Nidadavolu P, Valli RK, … Ravindranath V · FASEB J 2011

AKT (Ser/Thr) Phosphatase biology PhosphoSens

Study of the PDK1/AKT signaling pathway using selective PDK1 inhibitors, HCS, and enhanced biochemical assays

Hofler A, Nichols T, Grant S, … Ermolieff J · Anal Biochem 2011

PDK1, AKT1 & 2. (Ser/Thr) Signaling biology PhosphoSens

The phytosulfokine (PSK) receptor is capable of guanylate cyclase activity and enabling cyclic GMP-dependent signaling in plants

Kwezi L, Ruzvidzo O, Wheeler JI, … Irving HR · J Biol Chem 2011

PSKR1 (Ser/Thr) Signaling biology PhosphoSens

Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads

Oduor RO, Ojo KK, Williams GP, … Holler TP · PLoS Negl Trop Dis 2011

GSK-3 (HS & Tbru, Ser/Thr) Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

A p38α-selective chemosensor for use in unfractionated cell lysates

Stains CI, Luković E, Imperiali B · ACS Chem Biol 2010

Not specified Inhibitor discovery & SARSelectivity & kinome profilingCell & tissue lysate assaysAssay & sensor technology Technology origin

Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)

Pearce LR, Alton GR, Richter DT, … Alessi DR · Biochem J 2010

S6K1 (Ser/Thr) Inhibitor discovery & SAR PhosphoSens

Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance

Klüter S, Simard JR, Rode HB, … Rauh D · Chembiochem 2010

Src (Tyr), Covalent Inhibitors Covalent inhibitor kinetics PhosphoSens

Fluorescent peptide assays for protein kinases

Devkota AK, Kaoud TS, Warthaka M, Dalby KN · Curr Protoc Mol Biol 2010

Multiple Assay & sensor technologyReview Technology & reviews

Protein kinase A regulates GDNF/RET-dependent but not GDNF/Ret-independent ureteric bud outgrowth from the Wolffian duct

Tee JB, Choi Y, Shah MM, … Nigam SK · Dev Biol 2010

PKA (Ser/Thr) Signaling biology PhosphoSens

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis

Xie D, Gore C, Liu J, … Hsieh JT · Proc Natl Acad Sci U S A 2010

GSK-3b (Ser/Thr) Mechanism & structural biology PhosphoSens

Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts

Kroczek C, Lang C, Brachs S, … Mielenz D · J Immunol 2010

SYK (Ser/Thr) Mechanism & structural biology PhosphoSens

The presynaptic component of the serotonergic system is required for clozapine's efficacy

Yadav PN, Abbas AI, Farrell MS, … Roth BL · Neuropsychopharmacology 2010

CHEK2 (Ser/Thr) Signaling biology PhosphoSens

Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B and Aurora C kinases with an extremely long residence time1

Anderson K, Lai Z, McDonald OB, … Yang J · Biochem J 2009

Aurora B & C (Ser/Thr), Covalent Inhibitors Inhibitor discovery & SAR PhosphoSens

Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce

Ward B, Seal BL, Brophy CM, Panitch A · J Pept Sci 2009

MAPKAPK2/M K2 (Ser/Thr) Inhibitor discovery & SAR PhosphoSens

Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors

Timofeevski SL, McTigue MA, Ryan K, … Murray BW · Biochemistry 2009

cMET (HGFR; Tyr) Inhibitor discovery & SARSelectivity & kinome profiling PhosphoSens

Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab

Wheeler DL, Iida M, Kruser TJ, … Harari PM · Cancer Biol Ther 2009

Src-Family Kinases (Tyr), IP-kinase assays Signaling biology PhosphoSens

Inhibition of angiogenesis by extracellular protein kinase A

Szkudlarek M, Bosio RM, Wu Q, Chin KV · Cancer Lett 2009

PKA (Ser/Thr) Signaling biology PhosphoSens

Microfluidic concentration-enhanced cellular kinase activity assay

Lee JH, Cosgrove BD, Lauffenburger DA, Han J · J Am Chem Soc 2009

MAPKAPK2/M K2 & PKA (Ser/Thr). Microfluidics Cell & tissue lysate assays PhosphoSens

Monitoring protein kinases in cellular media with highly selective chimeric reporters

Luković E, Vogel Taylor E, Imperiali B · Angew Chem Int Ed Engl 2009

Not specified Cell & tissue lysate assays Technology origin

Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras

Lauchle JO, Kim D, Le DT, … Shannon K · Nature 2009

MAPKAPK2/M K2 (Ser/Thr) Signaling biology PhosphoSens

Syk tyrosine 317 negatively regulates osteoclast function via the ubiquitin-protein isopeptide ligase activity of Cbl

Zou W, Reeve JL, Zhao H, … Teitelbaum SL · J Biol Chem 2009

SYK (Tyr) Signaling biology PhosphoSens

Synthesis of red-shifted 8-hydroxyquinoline derivatives using click chemistry and their incorporation into phosphorylation chemosensors

González-Vera JA, Luković E, Imperiali B · J Org Chem 2009

Not specified Assay & sensor technology Technology origin

The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death

Miyawaki T, Ofengeim D, Noh KM, … Zukin RS · Nat Neurosci 2009

AKT (Ser/Thr) Signaling biology PhosphoSens

A rapid method for generation of selective Sox-based chemosensors of Ser/Thr kinases using combinatorial peptide libraries

González-Vera JA, Luković E, Imperiali B · Bioorg Med Chem Lett 2008

Not specified Assay & sensor technology Technology origin

Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists

Webb A, Johnson A, Fortunato M, … Jopling LA · J Leukoc Biol 2008

(Ser/Thr) Signaling biology PhosphoSens

Homogenous fluorescent assays for characterizing small-molecule activators of AMP-activated protein kinase (AMPK)

Reichling LJ, Riddle SM, Mei B, … Vogel KW · Curr Chem Genomics 2008

AMPK (Ser/Thr) Inhibitor discovery & SARMechanism & structural biologyAssay & sensor technology PhosphoSens

Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates

Li M, Luraghi P, Amour A, … Schaefer EM · Anal Biochem 2008

SYK (Tyr) Mechanism & structural biologyCell & tissue lysate assaysAssay & sensor technology AQT co-authored

Molecular mechanism of the Syk activation switch

Tsang E, Giannetti AM, Shaw D, … Bradshaw JM · J Biol Chem 2008

SYK (Tyr) Mechanism & structural biologyCell & tissue lysate assaysAssay & sensor technology PhosphoSens

Recognition-domain focused chemosensors: versatile and efficient reporters of protein kinase activity

Luković E, González-Vera JA, Imperiali B · J Am Chem Soc 2008

Not specified Selectivity & kinome profilingMechanism & structural biologyCell & tissue lysate assaysAssay & sensor technology Technology origin

Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors

Kolb P, Kipouros CB, Huang D, Caflisch A · Proteins 2008

EphB4 (Tyr) Inhibitor discovery & SARAssay & sensor technology PhosphoSens

Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells

Kawamura A, Baitsch D, Telgmann R, … Nofer JR · Arterioscler Thromb Vasc Biol 2007

PKA (Ser/Thr) Signaling biology PhosphoSens

Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay

Papp E, Tse JK, Ho H, … Bradshaw JM · Biochemistry 2007

SYK (Tyr) Mechanism & structural biologyAssay & sensor technology PhosphoSens

Optimal Sox-based fluorescent chemosensor design for serine/threonine protein kinases

Shults MD, Carrico-Moniz D, Imperiali B · Anal Biochem 2006

Not specified Assay & sensor technology Technology origin

A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates

Shults MD, Janes KA, Lauffenburger DA, Imperiali B · Nat Methods 2005

Not specified Cell & tissue lysate assaysAssay & sensor technology Technology origin

Versatile fluorescence probes of protein kinase activity

Shults MD, Imperiali B · J Am Chem Soc 2003

Not specified Assay & sensor technology Technology origin

Derivatives of 8-hydroxy-2-methylquinoline are powerful prototypes for zinc sensors in biological systems

Pearce DA, Jotterand N, Carrico IS, Imperiali B · J Am Chem Soc 2001

Not specified Assay & sensor technology Technology origin
No publications match those filters.